| Literature DB >> 23339295 |
Andrea Chambers1, Cameron A Mustard, Curtis Breslin, Linn Holness, Kathryn Nichol.
Abstract
BACKGROUND: Implementation effectiveness models have identified important factors that can promote the successful implementation of an innovation; however, these models have been examined within contexts where innovations are adopted voluntarily and often ignore the socio-political and environmental context. In the field of occupational health and safety, there are circumstances where organizations must adopt innovations to comply with a regulatory standard. Examining how the external environment can facilitate or challenge an organization's change process may add to our understanding of implementation effectiveness. The objective of this study is to describe implementation facilitators and barriers in the context of a regulation designed to promote the uptake of safer engineered medical devices in healthcare.Entities:
Mesh:
Year: 2013 PMID: 23339295 PMCID: PMC3556097 DOI: 10.1186/1748-5908-8-9
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Figure 1Proposed conceptual framework - Multi-level level influences on the implementation of safer engineered needles.
Foreshadowed issues and topical questions
| ● | Does needlestick injury prevention continue to be a priority for organizations? |
| ● | Are organizations continuing to improve the availability and quality of safety devices and monitoring issues with existing devices? |
| ● | Are existing goals to eliminate needlestick injuries through the uptake of SEMDs realistic considering device availability and utility? |
| ● | How have healthcare workers responded to the transition to SEMDs? Is there resistance to the use of these devices among specific groups of workers? |
| ● | Has the regulation stimulated the uptake of safer engineered devices beyond the regulatory requirements? |
| ● | Has the transition to SEMDs negatively impacted patient care in any way? |
| Initial implementation procedures and activities: | |
| ● | Was a sharps safety committee established? |
| ● | Did the process involve inventory review? |
| ● | What role did manufacturers have in facilitating the implementation process? |
| ● | Were SEMD pilot tested? |
| ● | Were workers involved in device selection? |
| ● | What kind of training and education on SEMD use and needlestick injury prevention was provided? |
| ● | Are there written policies and procedures in place? |
| Ongoing procedures and activities for sustained integration: | |
| ● | Are there activities in place to increase compliance with the use of SEMDs? |
| ● | Is the use of SEMDs monitored? How are issues addressed? |
| ● | Is there continued training and education on the use of SEMDs and needlestick injury prevention? |
| ● | Does the original sharps committee still meet? |
| ● | Are SEMDs beyond the regulatory requirements being considered? |
| Contextual questions about the transition: | |
| ● | When did the organization start to transition to the use of these devices? |
| ● | Are there still exceptions to the use of SEMDs? |
| ● | What do health and safety inspectors look for with regards to compliance with Ontario’s safer needle regulation |
| ● | Has the joint health and safety committee had a role in the implementation process? |
| ● | What are the organization’s ongoing health and safety priorities? |